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Neurodegenerative diseases target large-scale
neural networks. Four competing mechanistic hy-
potheses have been proposed to explain network-
based disease patterning: nodal stress, transneuro-
nal spread, trophic failure, and shared vulnerability.
Here, we used task-free fMRI to derive the healthy
intrinsic connectivity patterns seeded by brain re-
gions vulnerable to any of five distinct neurodegener-
ative diseases. These data enabled us to investigate
how intrinsic connectivity in health predicts region-
by-region vulnerability to disease. For each illness,
specific regions emerged as critical network ‘‘epi-
centers’’ whose normal connectivity profiles most
resembled the disease-associated atrophy pattern.
Graph theoretical analyses in healthy subjects re-
vealed that regions with higher total connectional
flow and, more consistently, shorter functional paths
to the epicenters, showed greater disease-related
vulnerability. These findings best fit a transneuronal
spreadmodel of network-based vulnerability. Molec-
ular pathological approaches may help clarify what
makes each epicenter vulnerable to its targeting dis-
ease and how toxic protein species travel between
networked brain structures.
INTRODUCTION
Neurodegenerative diseases have long been linked to neural
networks by the clinical and anatomical progression observed
in patients (Braak and Braak, 1991; Pearson et al., 1985;
Saper et al., 1987; Weintraub and Mesulam, 1996). Emerging
network-sensitive neuroimaging techniques have allowed
researchers to demonstrate that the spatial patterning of each
disease relates closely to a distinct functional intrinsic connec-
tivity network (ICN), mapped in the healthy brain with task-free
or ‘‘resting-state’’ fMRI (Buckner et al., 2005; Seeley et al.,
2009). Collectively, these findings raise mechanistic questions
about whether and how connectivity in health predicts regional
neurodegeneration severity in disease. In Alzheimer’s disease,
increasing evidence suggests that pathology may begin within1216 Neuron 73, 1216–1227, March 22, 2012 ª2012 Elsevier Inc.key vulnerable ‘‘hubs,’’ defined as central nodes within the
target network’s architecture (Buckner et al., 2009). Still, open
questions remain with regard to why each disease adopts
a network-related spatial pattern. At least four disease-general
hypotheses have been offered and can be summarized as (1)
‘‘nodal stress,’’ in which regions subject to heavy network traffic
(i.e., ‘‘hubs’’) undergo activity-related ‘‘wear and tear’’ that gives
rise to or worsens disease (Buckner et al., 2009; Saxena and
Caroni, 2011); (2) ‘‘transneuronal spread,’’ in which some toxic
agent propagates along network connections, perhaps through
‘‘prion-like’’ templated conformational change (Baker et al.,
1994; Frost and Diamond, 2010; Frost et al., 2009; Jucker and
Walker, 2011; Lee et al., 2010; Prusiner, 1984; Ridley et al.,
2006; Walker et al., 2006); (3) ‘‘trophic failure,’’ in which network
connectivity disruption undermines inter-nodal trophic factor
support, accelerating disease within nodes lacking collateral
trophic sources (Appel, 1981; Salehi et al., 2006); and (4) ‘‘shared
vulnerability,’’ in which networked regions feature a common
gene or protein expression signature that confers disease-
specific susceptibility evenly distributed throughout the network.
Although these hypothesized network degeneration mecha-
nisms need not be considered mutually exclusive, they make
competing predictions with regard to how healthy network archi-
tecture should influence disease-associated regional vulnera-
bility (Figure 1).
Here, we explored the relationship between healthy functional
architecture, as assessed with graph theoretical analyses of
task-free fMRI data, and neurodegenerative disease vulnera-
bility, as assessed by quantifying regional atrophy in patients.
Our previous work showed that each of five distinct neurodegen-
erative syndromes featured an atrophy pattern that mirrored
the healthy functional ICN seeded by the cortical region most
atrophied in patients with that syndrome (Seeley et al., 2009).
The present study, in contrast, examined every brain region
within the five disease-related atrophy maps to identify the
regions whose connectivity pattern in health most resembled
the atrophy map seen in each syndrome (see Figure 2 for
a methods schematic). The resulting dataset fully specified the
node pair connectivity strengths across all regions atrophied in
any of the five diseases; collectively, these regions traversed
most cerebral cortical and subcortical structures. With this
information in hand, we used graph theoretical analyses to test
model-based predictions of how network architecture in health
relates to disease-associated tissue loss (Figure 1). Although
previously described spatial atrophy patterns (Seeley et al.,
Figure 1. Predictions Made by Network-Based Degeneration Models: Effects of Healthy Intrinsic Connectivity Graph Metrics on Atrophy
Severity in Disease
A simplified healthy connectivity graph is shown (far left) for illustration purposes only; circles represent nodes (brain regions), lines represent edges (a connection
between two nodes), and edge lengths represent the connectivity strength between nodes, with shorter edges representing stronger connections. The orange
node represents an epicenter. Three nodes, labeled as A, B, and C, feature contrasting graph theoretical properties to illustrate predictionsmade by the network-
based vulnerability models (far right). Listed in the center column are the relationships predicted by each model. For example, the transneuronal spread model
predicts that nodes with shorter (Y) paths to the epicenter in health will be associated with greater ([) atrophy severity in disease. Justification for each model’s
prediction set is provided in the main text.
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study, all network connectivity analyses were performed on an
independent dataset of 16 healthy subjects aged 57 to 70
(8 females, all right-handed and psychoactive medication-free;
see Experimental Procedures). The resulting connectivity
patterns and graph metrics were used to relate each region’s
healthy connectivity profile to that region’s disease-specific
vulnerability, defined as its atrophy severity in patients.
RESULTS
Focal Epicenters Anchor Each Disease-Associated
Large-Scale Network
In previous work (Seeley et al., 2009), we identified re-
gional atrophy maxima for five neurodegenerative syndromes:
Alzheimer’s disease (AD), behavioral variant frontotemporal
dementia (bvFTD), semantic dementia (SD), progressive nonflu-
ent aphasia (PNFA), and corticobasal syndrome (CBS). Then,
using healthy subjects scanned with task-free fMRI, we used
these five atrophy maxima as ‘‘seed’’ regions to derive five
ICNs, representing regions whose blood-oxygen level-depen-
dent (BOLD) signal time-series significantly correlated with that
of the seed. The atrophy maxima seeded ICNs that resembled
the parent atrophy maps, supporting the view that neurodegen-
erative disease patterns are network based. By studying only
one seed region per atrophy pattern, however, this approach
could not determine which regions featured maximal con-
nectivity to the other vulnerable regions. We anticipated that
each disease-associated pattern would harbor focal ‘‘epi-
centers,’’ regions whose connectivity patterns—in the healthy
brain—most closely mirrored the disease vulnerability pattern.
To seek out these epicenters, here we took a more comprehen-
sive, data-driven approach by studying all regions within each ofthe five atrophy patterns. For example (Figure 2), we created
1,128 4 mm radius spherical regions of interest (ROIs) covering
the entire bvFTD atrophy pattern and built 1,128 functional ICN
maps, one seeded by each ROI, for each of our 16 healthy
subjects. We then derived 1,128 group-level ICN maps for
comparison to the (binarized) bvFTD atrophy pattern. Applying
this general strategy to all five syndromic atrophy patterns, we
used group-level goodness-of-fit (GOF) analyses (see Experi-
mental Procedures) to reveal five sets of distinct and focal
epicenters (Figure 3 and see Figure S1 and Table S1 available
online), whose large-scale connectivity maps in health showed
highest GOF to the binarized syndromic atrophy patterns.
Remarkably, although atrophy severity valuesmade no contribu-
tion to epicenter identification, the epicenters uncovered here
were seated in or near the most atrophic regions identified in
our previous work (Seeley et al., 2009; Figure S1), suggesting
that epicenters—in addition to being broadly connected with
regions atrophied in a disease—are often among the most atro-
phied (and perhaps earliest affected) regions in that disease.
Although the terms ‘‘epicenter’’ and ‘‘hub’’ have been used inter-
changeably to describe transmodal convergence zones within
healthy large-scale brain networks (Mesulam, 2012), we chose
‘‘epicenter’’ to describe the regions identified here because (1)
‘‘epicenter’’ carries a pathogenic connotation, describing a
region that is often but not necessarily the site of maximal
damage and (2) ‘‘hub’’ evokes a brain region with high node
centrality (‘‘hub-ness’’), as defined within the network science
lexicon. Our epicenter identification strategy, however, did not
include graph theoretical measures and thus provided no
guarantee that the identified epicenters would represent true
network hubs.
Having identified a set of focal epicenters within each atrophy
pattern, we next sought to examine where the epicenters fitNeuron 73, 1216–1227, March 22, 2012 ª2012 Elsevier Inc. 1217
Figure 2. Study Design Schematic
Atrophy maps from five neurodegenerative syndromes were delineated in a previous study (Seeley et al., 2009) and binarized to create five sets of 4 mm radius
spherical ROIs representing an epicenter ‘‘candidate pool’’ for each syndrome. Based on these pools, five steps were involved to infer the relationship between
healthy intrinsic functional connectivity and atrophy severity in disease: (1) the intrinsic functional connectivity of each ROI was derived with task-free fMRI data
from healthy controls, resulting in one whole-brain ICN map for each ROI; (2) regions whose ICNs in health featured significant goodness of fit (GOF) to the
binarized parent atrophy map were identified as ‘‘epicenters’’ at the group-level; (3) group-level weighted, thresholded healthy ICN matrices were constructed,
describing connectivity between all ROI pairs within the binarized atrophy template; (4) three graph theoretical metrics were calculated from the group-level ICN
matrices, including total flow (TF), shortest functional path to the epicenters (SPE), and clustering coefficient (CC); (5) correlation and stepwise regression
analyses were employed to examine the relationship between the three graph theoretical metrics in health and atrophy t scores in disease. This process was
carried out for each of five syndromic atrophy patterns; for illustration, the steps used for the bvFTD-related analyses are shown here.
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Connectional Architecture of Neurodegenerationwithin their target network’s functional architecture. To this end,
we generated five intra-network healthy connectivity matrices
covering all ROIs, including the epicenters, contained within
the five binary spatial atrophy patterns (Figure 3). Specifically,
we first generated unthresholded subject-level intranetwork
matrices, using ROIs as nodes and connectivity z scores
between ROI pairs as the weights of the undirected edges
(see Experimental Procedures). Group-level intranetwork
healthy connectivity matrices were then derived for each
network using one-sample t tests. Significant edges were deter-
mined by thresholding at p < 0.01, false discovery rate (FDR)
corrected for multiple comparisons across the matrix; nonsignif-
icant edges were assigned a weight of zero. Examination of
these matrices revealed that the epicenters related to each
disease showed broad-based connectivity with other nodes in1218 Neuron 73, 1216–1227, March 22, 2012 ª2012 Elsevier Inc.the target network, consistent with the manner in which they
were identified (Figure 3). We further questioned whether these
epicenters, though defined by their healthy ICN’s resemblance
to the (binary) parent atrophy pattern, might also serve as func-
tional hubs, defined as nodes with high weighted degree
centrality (total connectional flow) within the target network
(Sporns et al., 2007). As shown in Figure S2, although at least
some epicenters for each disease ranked among the nodes
highest in total intranetwork flow, this relationship remained
nuanced and varied by disease pattern, and many nonepicenter
regions showed equal or greater total flow. These observations
indicated that the amount of network traffic experienced by each
node may influence but does not determine the network’s
disease-critical epicenters. In addition, the dissociation between
epicenters and hubs suggested that graph metrics related to
Figure 3. Healthy Intrinsic Connectivity Matrices and Network Epicenters for Each of Five Neurodegenerative Syndrome Atrophy Patterns
Regions whose healthy ICN showed significant goodness of fit (GOF) to each of the five atrophy maps were identified as epicenters. A subset of these epicenters
is shown here superimposed on the MNI template brain (see Table S1 for additional details). The red-orange color bar represents the t scores associated with the
group-level significance of the epicenter GOF scores. Matrices representing the group-level node pairwise connectivity strengths were organized from left to right
(and top to bottom) in the order of frontal (F), temporal (T), parietal (P), occipital (O), paralimbic (Pl), limbic (L), and subcortical (S) regions. The blue-red color bar
represents the intrinsic connectivity between each node pair, defined as the t score from the thresholded group-level one-sample t test (see Experimental
Procedures). Subthreshold node pair connectivity strengths were colored dark blue and omitted from the matrices. See also Figures S1 and S2 and Table S1.
Amy, amygdala; ANG, angular gyrus; Cau, caudate; FI, frontoinsula; IFGoper, inferior frontal gyrus (pars opercularis); IFGtri, inferior frontal gyrus (pars trian-
gularis); l, left; pACC, pregenual anterior cingulate cortex; pHIP, parahippocampal gyrus; postCG, postcentral gyrus; preCG, precentral gyrus; Put, putamen; r,
right; TP, temporal pole.
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severity.
Nodes with Higher Intranetwork Centrality and
Functional Proximity to Epicenters in Health Show
Greater Vulnerability to Disease
Next, we sought to address how the brain’s healthy connectional
architecture, defined in a graph theoretical framework, relates to
disease-associated regional vulnerability, defined by atrophy
severity in patients. We translated the four major mechanistic
models into distinctive sets of connectivity-related predictions
(Figure 1). The nodal stress model would predict that metabolic
demands or other activity-dependent factors conferred byhigher nodal flow will accelerate vulnerability, worsening nodal
atrophy severity. The transneuronal spread hypothesis would
predict greatest degeneration in regions connectionally closest
to the node of onset, operationally defined here as those regions
having the shortest functional path to any of the epicenters. The
trophic failure model would predict that eccentric nodes with low
total flow and low clustering coefficients will prove less resilient
due to a lack of redundant trophic inputs. The shared vulnera-
bility model, in contrast to all others, predicts no direct impact
of intranetwork architecture on vulnerability, which is driven
instead by a common gene or protein expression profile.
To compare the model-based predictions, we used the
healthy intrinsic connectivity matrices (Figure 3) to generateNeuron 73, 1216–1227, March 22, 2012 ª2012 Elsevier Inc. 1219
Figure 4. Intranetwork Graph Theoretical Connectivity Measures in Health Predict Atrophy Severity in Disease
Regions with high total connectional flow (row 1) and shorter functional paths to the epicenters (row 2) showed significantly greater disease vulnerability (p < 0.05
familywise error corrected for multiple comparisons in AD, bvFTD, SD, PNFA, and CBS), whereas inconsistent weaker or nonsignificant relationships were
observed between clustering coefficient and atrophy (row 3). Cortical regions = blue circles; subcortical regions = orange circles. See also Tables S2–S5.
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network: total flow, shortest path to the epicenters, and
clustering coefficient (see Experimental Procedures). We then
examined the correlation between these nodal metrics, derived
from healthy subjects, and nodal atrophy severity in the five
neurodegenerative syndromes (Figure 4 and Table S2). A node’s
total flow in health showed a positive correlation with disease
vulnerability (Figure 4, row 1; p < 0.05 familywise error corrected
for multiple comparisons) in AD (r = 0.43, p = 8.4e40), bvFTD (r =
0.35, p = 4.9e36), SD (r = 0.29, p = 9.9e15), PNFA (r = 0.40, p =
5.4e7), and CBS (r = 0.40, p = 7.9e21). A shorter functional path
from a node to the disease-related epicenters also predicted
greater atrophy severity (Figure 4, row 2; p < 0.05 familywise
error corrected for multiple comparisons) in all five diseases:
AD (r = 0.62, p = 3.2e90), bvFTD (r = 0.30, p = 3.1e25), SD1220 Neuron 73, 1216–1227, March 22, 2012 ª2012 Elsevier Inc.(r = 0.60, p = 1.0e67), PNFA (r = 0.34, p = 1.2e5), CBS (r =
0.33, p = 7.0e13), an effect that remained significant after
controlling for the Euclidean distance (in Montreal Neurological
Institute [MNI] space) from each node to its functionally nearest
epicenter. Finally, no consistently significant positive or negative
correlations were identified between nodal clustering coefficient
and vulnerability across the five diseases (Figure 4, row 3): AD
(r = 0.15, p = 2.1e5), bvFTD (r = 0.05, p = 0.56), SD (r =
0.20, p = 9.9e8), PNFA (r = 0.16, p = 0.03), CBS (r = 0.28,
p = 7.7e11). To reinforce the pairwise correlation findings while
considering the influence of all network-based metrics together,
we performed stepwise linear regression analyses in which
atrophy served as the dependent measure, graphmetrics served
as independent predictors, and Euclidean distance from node to
epicenter and region type (cortical versus subcortical) were
Figure 5. Healthy Intrinsic Connectivity Matrix Representing all ROI Pairwise Interactions across the Five Neurodegenerative Syndrome
Atrophy Patterns
Matrices representing the group-level node pairwise connectivity strengths were organized from left to right (and top to bottom) in the order of AD, bvFTD, SD,
PNFA, and CBS regions. Ordering of regions within each disease pattern follows the scheme used in Figure 3. The blue-red color bar represents the intrinsic
connectivity strength between each node pair, defined as the t score from the thresholded group-level one-sample t test (see Experimental Procedures). See also
Tables S2–S5.
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although total flow accounted for a significant proportion of the
variance in atrophy severity for all five syndromes, the shortest
functional path to the epicenters explained more of the atrophy
variance within the AD and SD patterns (Table S3). Overall, these
intranetwork findings are compatible with both the nodal stress
and transneuronal spread models and suggest that these mech-
anisms may play differing roles in shaping regional vulnerability
across the five syndromes. Predictions derived for the trophic
failure and shared vulnerability models were not supported by
these experiments.
Off-Target Network Nodes with Greater Functional
Proximity to Epicenters in Health Show Greater
Vulnerability to Disease
Neurodegenerative diseases are known to spread from their
initial target network to ‘‘off-target’’ networks in later stages of
disease (Fo¨rstl and Kurz, 1999; Miller and Boeve, 2009; Seeley
et al., 2008). We reasoned that vulnerability within off-target
network regions may also be governed by connectional profile.
To test this idea, we created a single transnetwork connectivity
matrix including all ROIs in the five disease-related atrophy
maps (Figure 5) and recalculated the three graph metrics. Nodeswithin the transnetwork connectivity graph having shorter func-
tional paths to the disease-associated epicenters were associ-
ated with greater atrophy in patients with that disease (Figure 6,
row 2; Table S2; p < 0.05 familywise error corrected for multiple
comparisons) across all five diseases: AD (r = 0.27,
p = 8.1e46), bvFTD (r = 0.65, p < 1e300), SD (r = 0.54, p =
1.5e198), PNFA (r = 0.52, p = 3.5e183), and CBS (r = 0.54,
p = 2.1e197), an effect that remained significant after controlling
for the Euclidean distance from each node to its functionally
nearest epicenter. Total flow (AD [r = 0.08, p = 1.8e5], bvFTD
[r = 0.29, p = 6.7e51], SD [r =0.30, p = 7.2e57], PNFA [r = 0.26,
p = 1.2e41], CBS [r = 0.33, p = 4.6e67]) and clustering coeffi-
cient (AD [r = 0.0, p = 0.06], bvFTD [r = 0.21, p = 7.8e28], SD
[r = 0.38, p = 5.2e91], PNFA [r = 0.19, p = 1.1e22], CBS
[r = 0.21, p = 1.7e26]), in contrast, exerted a weaker and incon-
sistent influence on atrophy severity across the five diseases
(Figure 6, rows 1 and 3; Table S2). Following the same approach
taken for the intranetwork analyses, a stepwise linear regression
performed at the transnetwork level revealed that the shortest
functional path to the epicenters stood out as the single
strongest graph metric predictor across all five syndromes
(Table S3). Similar results were obtained when including
Euclidean distance from each node to its functionally nearestNeuron 73, 1216–1227, March 22, 2012 ª2012 Elsevier Inc. 1221
Figure 6. Transnetwork Graph Theoretical Connectivity Measures in Health Predict Atrophy Severity in Disease
Row 2: ROIs showing greater disease-related atrophy were those featuring shorter functional paths, in the healthy brain, to the disease-associated epicenters
(p < 0.05 familywise error corrected for multiple comparisons for AD, bvFTD, SD, PNFA, and CBS). Row 1 and 3: Inconsistent weaker or nonsignificant
relationships were observed between total flow or clustering coefficient and disease-related atrophy. See also Tables S2–S5.
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a substantial proportion of atrophy variance, reducing the
contribution from the shortest path to the epicenters. The strong
relationship between functional proximity to the epicenters and
atrophy severity emerged from these transnetwork analyses
even though most nodes contributing to each analysis came
from ‘‘off-target’’ networks that made no contribution to
epicenter identification. Nonetheless, to eliminate the possibility
that node selection bias contributed to the observed relation-
ships, we repeated the transnetwork correlation and stepwise
regression analyses after removing all ROIs within each target
network, thereby examining only how the connectivity of ‘‘off-
target’’ network nodes predicts vulnerability. These additional
control analyses showed that a node’s shortest functional path
to the target network epicenters remained the most robust and1222 Neuron 73, 1216–1227, March 22, 2012 ª2012 Elsevier Inc.consistent predictor of that node’s atrophy in the target disease
(Tables S4 and S5). Overall, these findings suggest that although
both the nodal stress and transneuronal spread models are
consistent with the intranetwork analysis, incorporating off-
target networks provided stronger support for the transneuronal
spread hypothesis. Furthermore, the transnetwork graphmetrics
converge with previous studies investigating the relationships
between the five neurodegenerative syndromes. For example,
consistent with our previous findings that bvFTD and AD feature
divergent intrinsic connectivity changes (Zhou et al., 2010), the
nodes within the AD and bvFTD patterns featured the most
dissimilar healthy connectional profiles and disease-associated
atrophy severities (Figure 6). Regions within the bvFTD pattern
showed the lowest atrophy in AD and had among the longest
paths to the AD-related epicenters and vice versa.
Neuron
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The present results provide insights regarding how the brain’s
functional architecture shapes vulnerability to neurodegenera-
tive disease. We found that each of five neurodegenerative
patterns contains focal network epicenters whose healthy brain
connectivity profiles strongly resemble the parent atrophy
pattern. Although previous studies have demonstrated the simi-
larity between single seed-based healthy ICNs and disease-
related atrophy (Buckner et al., 2005; Seeley et al., 2009),
the present study used a comprehensive, high-dimensional
network mapping strategy to seek out those regions with
connectivity maps most closely aligned with five patterns of
disease-associated vulnerability. We then used graph theoret-
ical approaches to seek disease-general principles governing
connectivity-vulnerability interactions, testing predictions made
by four proposed models of network-based neurodegeneration.
We found that, within each targeted network, a node’s vulner-
ability was best predicted by greater total connectional flow
through that node and by a shorter functional path to the
disease-related epicenters. Extending this analysis across all
regions contained in any of the five networks revealed that
intrinsic functional proximity to the epicenters represents the
most potent predictor of disease-related atrophy. Therefore,
although both the nodal stress and transneuronal spread model
predictions received support from analyses of the individual
target networks, incorporating the off-target networks provided
strongest support for the notion that neurodegenerative
diseases spread from region to region along connectional lines
to adopt a network-based spatial pattern.
Exploring the Target Networks: Epicenters and Early
Disease Spread
The most mysterious aspect of neurodegenerative disease
regards how each disease selects its initial target or targets.
Early selective vulnerability, though not the focus of this study,
creates a starting point from which disease then spreads.
Regions showing greatest atrophy at later stages may or may
not represent the sites of initial injury, and even longitudinal
imaging studies that follow patients from health to disease may
overlook incipient microscopic pathology within small neuronal
populations (Braak et al., 2011). Despite these important
caveats, our findings converge with our previous work to
suggest that the regionsmost atrophied in each syndrome repre-
sent disease-specific network ‘‘epicenters,’’ whose connectivity
in health serves as a template for the spatial patterning of
disease. These epicenters bear close relationships to the early
clinical deficits that define each parent syndrome. In AD, the
angular gyrus may serve as the key heteromodal association
hub through which information flows from posterior unimodal
and polymodal association cortices to modules specialized for
the memory, visuospatial, language, and praxis functions lost
in patients with AD. Because atrophy in AD is more closely
related to tau neurofibrillary than amyloid plaque pathology
(Scheinin et al., 2009; Whitwell et al., 2008), we suspect that
our connectivity-vulnerability findings in AD largely reflect tau
pathology within posterior elements of the large-scale network
known as the default mode network (Greicius et al., 2003,2004). Nonetheless, the hub-like nature of the angular gyrus
may produce activity-dependent ‘‘wear and tear’’ or increases
in amyloid production that heighten its early vulnerability to
amyloid deposition (Buckner et al., 2009) and incite or com-
pound the neurodegenerative process. Interestingly, numerous
frontal regions exhibit striking resistance to AD-related neurode-
generation despite having high fibrillar amyloid-beta deposition
(Jack et al., 2008) and, as shown here, short functional paths
to the angular gyrus in some instances. This disconnect may
reflect the complexity of underlying AD pathology which, in con-
trast to all other diseases studied here, features two co-occur-
ring major molecular pathologies (amyloid-beta and tau). In
bvFTD, the identified epicenters in the right frontoinsula and
pregenual anterior cingulate cortex are known for their coactiva-
tion during salience processing (Seeley et al., 2007), and both
regions harbor a unique class of large, bipolar projection neurons
targeted in early-stage bvFTD (Kim et al., 2011; Seeley et al.,
2006). The anterior temporal epicenters identified within the
SD pattern feature prominent connections to upstream cortices
that may converge on the epicenters to foster multimodal
semantic integration (Patterson et al., 2007). In PNFA, our
epicenter search identified the inferior frontal gyrus (Broca’s
area), as well as striatal and thalamic sites with robust
operculofrontal connections (Alexander et al., 1986). The CBS
epicenters occupy the rolandic and perirolandic cortices
involved in skeletomotor planning, control, and execution func-
tions compromised early in the course of typical CBS regardless
of the underlying pathology (Lee et al., 2011).
How does disease spread throughout the network once one of
its key epicenters is compromised? The present data suggest
that at least two major factors influence spread within the target
network. First, across all five diseases, network nodes subject to
greater intranetwork total connectional flow were found to
undergo greater atrophy. This observation raises the possibility
that activity-dependent mechanisms, such as oxidative stress,
local extracellular milieu fluctuations, or glia-dependent phe-
nomena, influence regional neurodegeneration severity. Further-
more, nodes with shorter connectional paths to an epicenter
showed greater vulnerability, suggesting that transneuronal
spread represents one of the key factors driving early target
network degeneration. In this regard, epicenter infiltration by
disease may provide privileged but graded access across the
network that determines where the disease will arrive next.
Although trophic factor insufficiency or a shared gene or protein
expression profile may help to determine sites of initial vulnera-
bility, the present findings are more difficult to reconcile with
these models.
Disease Progression into Off-Target Networks:
Transneuronal Spread
Regions exquisitely vulnerable to one neurodegenerative
disease are often spared in another. On the other hand, once
disease has spread throughout its target network, the process
often extends into ‘‘neighboring’’ networks, defined as those
with stronger functional relationships to the primary target
network (Seeley et al., 2008). We reasoned that these observa-
tions might be best explained within a connectivity-based
framework. Combining data across all five disease-vulnerableNeuron 73, 1216–1227, March 22, 2012 ª2012 Elsevier Inc. 1223
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cerebral gray matter volume), we found greater atrophy among
off-target network regions with shorter functional paths to the
target network’s focal epicenters. Combining the intranetwork
and transnetwork findings, these data provide strongest support
for the transneuronal spread model, which predicts that the
strength of any node’s functional connectivity to an epicenter
will determine that node’s ultimate vulnerability to a neurodegen-
eration once the disease has taken hold. In contrast to the intra-
network analysis, we found no consistent evidence for the nodal
stress model’s predictions at the transnetwork level, perhaps
because across a broader brain network space a node’s
centrality need not determine its susceptibility to every disease
process. As seen at the intra-network level, at the transnetwork
level we found no consistent evidence supporting predictions
derived from the trophic failure or shared vulnerability models.
Limitations and Future Directions
Several important limitations of this study should be noted. The
AD group used to define the anatomical pattern studied here
included patients with early age-of-onset AD, which features
a more distributed cortical pattern when compared to the hippo-
campal-predominant pattern seen in late age-of-onset patients
(Kim et al., 2005). This factor could account, at least in part, for
the identification of the angular gyrus as the lone epicenter within
the AD pattern. The present analyses used regional functional
connectivity approaches in a healthy older control group to
predict neurodegeneration severity in patients. Although the
human connectome evolves with aging (Zuo et al., 2010), we
chose healthy older subjects to capture the connectome upon
which neurodegeneration is most often superimposed. Although
we cannot exclude preclinical neurodegeneration in our control
sample, each subject was screened with a battery of neuropsy-
chological tests and found to perform within normal limits for
age. The ideal approach for predicting neurodegeneration from
connectivity data would be to follow individuals from health to
disease, exploring connectivity-vulnerability interactions within
single subjects. Although this approach may prove challenging
for the FTD syndromes studied here, future longitudinal analyses
of this type should become feasible for AD through large,
ongoing, collaborative longitudinal studies.
Although we used the same five group-level atrophy maps to
identify the epicenter ‘‘candidate pool’’ for each disease and to
assess connectivity-vulnerability relationships, several key
design elements prevented circularity. First, atrophy severity
served as the major outcome variable but was not involved in
epicenter identification. Second, the healthy network matrices
used for calculating graph metrics were epicenter-independent,
composed of every regionwithin each binary atrophymap. Third,
the transnetwork graphs and analyses (Figures 5 and 6) spanned
regions from all five binary atrophy maps. Therefore, most
regions used in these analyses were not involved in the identifi-
cation of any given epicenter, and even limiting the transnetwork
analyses to off-target network regions produced little change in
the major findings.
Our correlation-based intrinsic functional connectivity ap-
proaches only measure symmetric (undirected) connections
between regions with temporally synchronous BOLD fluctua-1224 Neuron 73, 1216–1227, March 22, 2012 ª2012 Elsevier Inc.tions. These methods cannot differentiate direct from indirect
links or infer causality (direction of information flow). These limi-
tations apply to all current intrinsic functional network analyses in
humans because the true graph (determined at the microscopic
level by the presence of axonal connections between regions)
cannot be determined with existing methods. We attempted to
mitigate these concerns by thresholding the graphs at a stringent
statistical threshold, leaving only strong edges for calculation of
graph metrics, but this approach does not preclude our edges
from representing indirect connections within or outside the
network. Despite these limitations, the functional network
graphs derived here provide relevant data about network
organization.
Potential Implications for Cellular-Molecular Biology
of Neurodegeneration
Understanding the cellular and molecular basis for network-
based disease spread represents an important priority for neuro-
degenerative disease research. Human intrinsic connectivity
data cannot directly inform cellular pathogenesis models, just
as simple laboratory models include assumptions regarding
their relevance to human disease. This study sought to bridge
these research streams by translating mechanistic network-
based neurodegeneration models into simple but rational pre-
dictions regarding the relationships between network connec-
tivity and vulnerability. Complementary studies using structural
connectivity data could further explore connectivity-vulnerability
interactions. The present findings suggest that, overall, a trans-
neuronal spread model best accounts for the network-based
vulnerability observed in previous human neuropathological
and imaging studies. Several mechanisms of transneuronal
spread have been proposed, including axonal transport of unde-
tected viruses or toxins (Hawkes et al., 2007; Saper et al., 1987).
Providing a more parsimonious account, growing evidence
suggests that prion-like mechanisms may promote the spread
of toxic, misfolded, nonprion protein species between intercon-
nected neurons (Baker et al., 1993, 1994; Brundin et al., 2010;
Clavaguera et al., 2009; Frost and Diamond, 2010; Frost et al.,
2009; Hansen et al., 2011; Jucker and Walker, 2011; Lee et al.,
2010; Li et al., 2008; Ridley et al., 2006; Walker et al., 2006).
This notion, that many or all noninfectious neurodegenerative
diseases may propagate along networked axons via templated
conformational change, has been put forth since the introduction
of the prion concept (Prusiner, 1984, 2001). Although our data
cannot exclude contributions from failed trophism or shared
vulnerability, the present human findings complement the recent
tide of cell-based and rodent disease model data to suggest that
prion-like transneuronal spreading mechanisms merit further
aggressive investigation.
EXPERIMENTAL PROCEDURES
Subjects
Patients with neurodegenerative syndromes who defined the five disease-
vulnerable ROI sets were those studied previously as described (Seeley
et al., 2009). Clinical diagnostic criteria and clinicopathological correlation
data are detailed in the Supplemental Experimental Procedures. In addition,
we studied 16 healthy controls (8 females, all right-handed, mean age 65.4
(s.d. 3.2) years, psychoactive medication-free, not included in our previous
Neuron
Connectional Architecture of Neurodegenerationwork (Seeley et al., 2009)) evaluated at the UCSFMemory and AgingCenter. All
subjects provided informed consent, and the procedures were approved by
the UCSF Committee on Human Research. Healthy subjects were recruited
from the local community through advertisements and underwent a compre-
hensive neuropsychological assessment and a neurological exam within
180 days of scanning. All controls met the criteria of having a Clinical Dementia
Rating scale total score of 0, a mini-mental state examination score of 28 or
higher, no significant history of neurological disease or structural lesions on
MRI, and a consensus diagnosis of cognitively normal.
Image Acquisition
All subjects underwent an eight-minute task-free or ‘‘resting-state’’ functional
magnetic resonance (fMRI) scan after being instructed to remain awake with
their eyes closed. Functional and structural images were acquired on a 3 Tesla
Siemens MRI scanner at the Neuroscience Imaging Center, University of
California, San Francisco. Functional MRI scanning was performed using
a standard 12-channel head coil. Thirty-six interleaved axial slices (3 mm thick
with a gap of 0.6mm) were imaged parallel to the plane connecting the anterior
and posterior commissures using a T2*-weighted echo planar sequence
(repetition time [TR]: 2,000 ms; echo time (TE): 27 ms; flip angle [FA]: 80; field
of view: 230 3 230 mm2; matrix size: 92 3 92; in-plane voxel size: 2.5 3
2.5 mm). For coregistration purposes, a volumetric magnetization prepared
rapid gradient echo (MPRAGE) MRI sequence was used to obtain a
T1-weighted image of the entire brain in sagittal slices in the same session
(repetition time, 2300 ms; echo time, 2.98 ms; inversion time, 900 ms; flip
angle, 9). The structural images were reconstructed as a 160 3 240 3 256
matrix with 1 mm3 spatial resolution.
Image Preprocessing
After discarding the first 16 s to allow for magnetic field stabilization, func-
tional images were realigned and unwarped, slice-time corrected, coregis-
tered to the structural T1-weighted image, normalized, and smoothed with
a 4 mm full-width at half-maximum Gaussian kernel using SPM5 (http://
www.fil.ion.ucl.ac.uk/spm/), resulting in images with a voxel size of 2 mm3.
Coregistration was performed between each subject’s mean T2* image and
that subject’s T1-weighted image, and normalization was carried out by calcu-
lating the warping parameters between the subject’s T1-weighted image and
the MNI T1-weighted image template and applying those parameters to all
functional images in the sequence.
Seed-Based ICN Derivation
Previously we delineated the atrophy patterns associated with five neu-
rodegenerative disease syndromes by comparing patients to controls using
voxel-based morphometry (VBM) (Seeley et al., 2009). Here, we examined
the healthy functional intrinsic connectivity architecture for all ROIs that could
be situated within the five previously published atrophy patterns. To this end,
we binarized the five atrophy maps and created five sets of 4mm radius spher-
ical ROIs for each map (Figure 2, step 1). Preprocessed task-free fMRI data
from 16 healthy subjects were then used for ROI-based intrinsic connectivity
network (ICN) analyses, seeding all ROIs in each of the five atrophy patterns,
resulting in one intrinsic connectivity map for each ROI. The ROI-based ICN
analyses followed previous methods (Seeley et al., 2009). That is, the average
time series from each ROI within the disease-associated pattern was used as
a covariate of interest in a whole-brain regression analysis, and the global
signal was entered as a nuisance variable. The voxel-wise z scores in the
resulting subject-level ICN maps described the correlation between each
voxel’s spontaneous BOLD signal time series and the average time series of
all voxels within the seed ROI. ICN maps were derived from each ROI in
each individual and entered into second-level, random effects analyses to
derive group-level ICN maps for each ROI.
Identification of Disease-Associated Network Epicenters
We defined epicenters as regions whose pattern of seed-based intrinsic
connectivity in health best fit the disease-related binary atrophy pattern from
which the region was taken (Figure 2, step 2). At the level of the individual
healthy subjects, we assigned one GOF score to each ROI based on the simi-
larity between its healthy ICN map and the target binarized atrophy map. TheGOF score was calculated by multiplying (1) the average z score difference
between voxels falling within the atrophy map and voxels falling outside the
map and (2) the difference in the percentage of positive z score voxels inside
and outside the atrophy map (Zhou et al., 2010). In this way, atrophy severity
values were omitted from the GOF calculation. For each atrophy pattern,
a one-sample t test on the corresponding GOF maps from the sixteen healthy
subjects was used to identify those ROIs (epicenters) with significant GOF
scores, stringently thresholded at p < 0.05, familywise error corrected for
multiple comparisons (Figures 3 and S1) to isolate only the few regions whose
connectivity most closely resembled the disease-associated atrophy map.
The threshold for the SD. GOF map was set to p < 0.0001 (uncorrected) to
adjust for signal loss within temporal pole and orbitofrontal regions that
make up the SD pattern.
Group-Level Intra- and TransnetworkConnectivityMatrixDerivation
To study the healthy intrinsic functional connectome related to each set of
disease-vulnerable regions, we derived group-level intra- and transnetwork
connectivity matrices (Figure 2, step 3). Here, the intranetwork matrices repre-
sent all ROIs within each target network (defined using the binarized atrophy
maps), whereas the transnetwork matrix represents all ROIs across the five
target networks. These matrices were derived as follows. We first extracted
the subject-level intranetwork matrices from the seed-based ICN maps of
each ROI set, using ROIs as nodes and mean connectivity z scores between
ROI pairs as the weights of the undirected edges (Watts and Strogatz,
1998). Edge weight for every node pair (e.g., nodes A and B) was defined
at the subject level as the higher of two connectivity scores (A to B and B
to A) for the A-B pair, where A to B connectivity was derived by (1) calculating
the mean time series across all voxels in node A, (2) determining the z scores
for the connectivity of the node A time series to each voxel within node B, and
(3) averaging the resulting z scores to create a single score. The B to A connec-
tivity score was derived in like manner by reversing A and B in the procedure
described above. This procedure made use of the extensive seed-based
voxel-wise connectivity data generated for epicenter identification while
producing nearly identical node pair connectivity results, in pilot analyses, to
those derived by calculating the correlation between the mean time series
from nodes A and B. We then generated the group-level intranetwork
adjacency matrix containing significant connections by performing a one-
sample t test on the group of intranetwork matrices, stringently thresholded
at p < 0.01, FDR corrected for multiple comparisons to avoid potentially
spurious links introduced by low temporal resolution and hemodynamic blur-
ring in the fMRI signal. The same process was performed for each of the five
ROI sets, resulting in five thresholded intranetwork healthy functional intrinsic
connectivity matrices (Figure 3). A lower statistical threshold of p < 0.05, FDR
corrected for multiple comparisons, was used for the SD pattern to adjust for
the fMRI signal loss characteristic of the temporal pole and orbitofrontal
regions contained in this network, following previous approaches (Devlin
et al., 2000; Seeley et al., 2009). A single healthy transnetwork connectivity
matrix, including all ROIs across the five atrophy patterns as one network,
was constructed in like manner. In the group-level ICN matrices, the pairwise
ROI connectivity t scores resulting from one-sample t test were used as edge
weights.
Graph Theoretical Analyses
To study how intrinsic network architecture in health relates to disease-asso-
ciated vulnerability, we examined three graph theoretical metrics for every
network node (Figure 2, step 4) in both the intranetwork (Figures 3 and 4)
and transnetwork (Figures 5 and 6) group-level healthy ICN adjacency
matrices, including (1) total flow—the sum of the magnitudes of the weighted
connections passing through each node, (2) shortest intrinsic functional path
to the epicenters—the minimum path length to any of the identified epicenters
for the atrophy pattern of interest, and (3) clustering coefficient—the ratio of the
number of edges between a node’s neighbors to the total possible number
of edges between the node’s neighbors (Watts and Strogatz, 1998). Graph
theoretical measures were calculated using in-house MATLAB programs
based on the publicly available Matlab BGL graph library developed by David
Gleich (https://github.com/dgleich/matlab-bgl). Corresponding mathematical
notation has been provided (Rubinov and Sporns, 2010). For atrophy patternsNeuron 73, 1216–1227, March 22, 2012 ª2012 Elsevier Inc. 1225
Neuron
Connectional Architecture of Neurodegenerationfeaturing multiple epicenters, we chose each ROI’s shortest among the
shortest paths to each epicenter in the matrix. For intranetwork analyses,
graph metrics were based solely on ROIs within each target network pattern,
whereas for transnetwork analyses we considered ROIs in all five networks
together. We limited our analyses to these three metrics because the four
prevailing models of network-based neurodegeneration could be used to
generate distinguishing predictions regarding the relationship between these
metrics and disease-associated atrophy severity (Figure 1).Correlation between Healthy Network Graph Metrics
and Disease-Associated Atrophy
To test predictions about the relationship between the three graphmetrics and
disease-associated atrophy severity, we performed five separate intranetwork
correlation analyses between disease-associated atrophy and the three nodal
graphmetrics across all ROIs within each of the five disease patterns (Figure 2,
step 5; Figure 4). Here, atrophy severity was defined using a previous VBM
comparison of patients to age-matched controls (Seeley et al., 2009) and aver-
aging the voxel-wise t scores from this comparison across each 4 mm radius
spherical ROI used as a node in the present graph theoretical computations.
Five similar transnetwork correlation analyses (all on the same combined
node set) were performed to assess whether the same principles applied to
off-target networks (Figure 6). For the intra- and transnetwork correlation anal-
yses, statistical significance was set to p < 0.05, familywise error corrected for
multiple comparisons across three graph metrics, five atrophy patterns, and
three node sets (all, cortical only, and subcortical only; see Table S2 and Fig-
ure 4) for a total of 45 statistical tests. In assessing the relationship between
the shortest functional path to the epicenters and atrophy, we used partial
correlation to further control for the Euclidean distance between each node
and its functionally nearest epicenter. One step further, to take into account
the influence of all network-based metrics, we performed stepwise linear
regression analyses in which atrophy served as the dependent measure, the
three graph metrics served as independent predictors, and cortical versus
subcortical (binary membership) and Euclidean distance between each node
and its functionally nearest epicenter served as nuisance variables (Table
S3). Finally, we repeated the transnetwork correlation and stepwise regression
analyses for all ROIs within the four off-target networks only, i.e., removing the
ROIs in the target network which contributed to epicenter identification (Tables
S4 and S5).SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures, five tables, and Supplemental
Experimental Procedures and can be found with this article online at
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